Workflow
Enliven Therapeutics Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Prnewswire· 2025-06-13 13:30
BOULDER, Colo., June 13, 2025 /PRNewswire/ -- Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced that it has priced its previously announced underwritten public offering of 8,394,737 shares of its common stock at a price to the public of $19.66 per share and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase up to 1,780,263 sha ...
CVE Makes Complete Output Restoration at Christina Lake Site
ZACKS· 2025-06-13 13:26
Key Takeaways CVE resumed full output at Christina Lake on June 12 after a safe restart following wildfire threats. No infrastructure was damaged, and emergency protocols ensured a smooth and controlled ramp-up. Christina Lake remains a top-performing, low-cost asset that supports CVE in achieving its long-term goals.Cenovus Energy Inc. (CVE) has resumed full production at its Christina Lake oil sands facility in northeastern Alberta after wildfire threats in the region prompted a temporary shutdown. The ...
Here's Why You Should Include UGI Stock in Your Portfolio Right Away
ZACKS· 2025-06-13 13:26
Key Takeaways UGI plans $800-$900M in fiscal 2025 and up to $4.1B by 2027 to modernize infrastructure. Fiscal 2025 EPS estimate rose 3.3% to $3.13, with sales expected to grow 8.4% to $7.81B. UGI's 16.21% ROE and 141-year dividend track record underscore consistent performance.UGI Corporation’s (UGI) planned investments should help upgrade and replace its aging infrastructure and boost its overall performance. Given its growth opportunities and strong return on equity (ROE), UGI makes for a solid investme ...
Regarding the investment in the share capital of UAB "Ateities ūkis"
Globenewswire· 2025-06-13 13:26
In order to promote the production of raw milk in Lithuania, AB "Rokiškio sūris" has invested EUR 10 million in to the authorized capital of UAB "Ateities ūkis" by acquiring 29.67 per cent of the authorized capital. UAB "Ateities ūkis" is a company belonging to the Agrokoncernas group, one of the main activities of which is the production of raw milk. In the opinion of the management of AB Rokiškio sūris, this transaction is beneficial for the company, as it will ensure an increase in the production of high ...
Airlines divert, cancel flights after Israel's strike on Iran closes airspace in Middle East
CNBC· 2025-06-13 13:25
Flight map of the Middle East after Israel airstrikes on Iran at 12:25 UTC on June 13th, 2025.Airlines around the world canceled flights to Israel and were skirting a large swath of airspace in the Middle East on Friday after Israel's overnight missile strike on Iran. Iran later launched drones toward Israeli territory.Delta Air Lines and United Airlines canceled service to Tel Aviv, Israel, through at least Saturday. Both carriers' Tel Aviv-bound flights turned around over the Atlantic Ocean to return to t ...
Zhihu: A High-Quality Company Trading At Half Its Cash Balance - With Hidden AI Upside
Seeking Alpha· 2025-06-13 13:25
Editor's note: Seeking Alpha is proud to welcome Max Capital as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access.Portfolio Manager and Managing Partner of Max Capital since inception. Previously a Senior Research Analyst at OppenheimerFunds (acquired by Invesco) for almost 9 years and a Management Consultant at Bain & Co. for 2 years.Analyst’s Disclosure: ...
Six Flags Entertainment: I'm Not Getting On This Roller Coaster
Seeking Alpha· 2025-06-13 13:24
Core Viewpoint - Six Flags Entertainment Corporation (FUN) shares are experiencing a significant decline, resembling a straight drop rather than the expected upward movement [1] Group 1 - The performance of Six Flags shares is likened to a roller coaster, indicating volatility but not in a favorable direction for shareholders [1]
Rocket Pharmaceuticals, Inc. (RCKT) Faces Securities Class Action Amid Protocol Change and FDA's Clinical Hold on Gene Therapy Trial - Hagens Berman
Prnewswire· 2025-06-13 13:23
RCKT Investors with Losses Encouraged to Contact the FirmSAN FRANCISCO, June 13, 2025 /PRNewswire/ -- A securities class action lawsuit styled Ho v. Rocket Pharmaceuticals, Inc., et al., No. 3:25-cv-10049 (D. N.J.) has been filed and seeks to represent investors who purchased or otherwise acquired Rocket Pharmaceuticals securities between February 27, 2025 and May 26, 2025.The lawsuit comes after investors saw the price of their shares in Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) crash over 60% on May 27, ...
Eni Monitors Iraq's Security Situation Amid US Embassy Evacuation
ZACKS· 2025-06-13 13:20
Key Takeaways E continues operations at the Iraq Zubair field despite the U.S. embassy exit and rising tensions. The company follows strict security protocols and employs over 500 personnel, mostly international staff. E views regional instability as a key risk but remains committed to protecting assets and business continuity.Italian energy major Eni S.p.A. (E) is keeping a close watch on the evolving security conditions in Iraq following the U.S. decision to evacuate its embassy in the country. A spokes ...
BSX Q1 Endoscopy Sales Rise 6%: What's Behind the Growth?
ZACKS· 2025-06-13 13:20
Key Takeaways BSX's Endoscopy revenues rose 6% to $673M in Q1 2025, making up 14% of total company sales. Growth was fueled by strong global demand and high adoption of BSX's advanced GI treatment technologies. Boston Scientific's AXIOS, OverStitch, and MANTIS tools saw double-digit growth, driving segmental momentum.Boston Scientific’s (BSX) Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) conditions using innovative, less invasive technolo ...